RecruitingNot Applicable

Dysthymia: Associated Costs, Treatment and Change Process

Norway80 participantsStarted 2016-01

Plain-language summary

The study evaluates cost and effect of inpatient versus outpatient treatment of dysthymia, as well as investigates the processes through which psychotherapy works in treating dysthymia.

Who can participate

Age range18 Years – 70 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Inclusion criteria will be liberal and similar to clinical practice criteria at the treatment site: Persistent depressive disorder as defined by the diagnostic and statistical manual of mental disorders (DSM5); which includes an International classification of disorders-10 (ICD-10) diagnosis of depression, dysthymia, recurrent depression. unsuccessful previous treatments. living within driving distance from the treatment facilities. Exclusion Criteria: * current suicidal risk, current psychosis, marked emotional instability (i.e. issues with impulsivity), strong paranoid traits, current problems related to heavy substance abuse.

What they're measuring

Change in Depressive symptoms

Timeframe: At assessment, start (12 weeks after assessment) and end (24 weeks after assessment) of therapy, and at one-year follow up (76 weeks after assessment).

Change in Depressive symptoms

Timeframe: Once every week for the 12 weeks of active psychotherapy

Change in Cost of living with dysthymia

Timeframe: pre therapy, one-year and 10 years

Trial details

NCT IDNCT04911829

SponsorModum Bad

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2021-12

Contact for this trial

Pål Ulvenes, PhD

32749857 pal.ulvenes@modum-bad.no

View on ClinicalTrials.gov More Depression trials